{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:15:10Z","timestamp":1768436110727,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Outcomes of childhood hematolymphoid malignancies have improved several fold because of immunosuppressive chemotherapy and broad-spectrum antibiotics for managing febrile neutropenia. An apparent trade-off has been an increase in invasive fungal disease (IFD), affecting multiple organs. We report the diagnostic and therapeutic challenges in 8 children with lymphoid cancers who developed intracranial (IC) fungal abscesses between 2010 and 2017.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Children below 15 years of age undergoing treatment for leukemia\/lymphoma with clinicoradiologic and microbiologic evidence of IC fungal abscess were included. Demographic details, clinical profile, and management were retrospectively audited. Treatment was guided by European Organization for Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) definitions for IFD with therapeutic drug monitoring (TDM)-directed azole dosing, and surgical intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eight patients (4 B-cell acute lymphoblastic leukemia, 2 relapsed B-cell acute lymphoblastic leukemia, and 2 non-Hodgkin lymphoma) were eligible for analysis. Proven, probable, and possible IFDs were seen in 2 (25%), 4 (50%), and 2 (25%) patients, respectively. Proven IFDs were invasive mucormycosis with remaining having mold infections. Cerebrospinal fluid galactomannan was positive in all 4 patients in whom it was tested. TDM was possible in 5\/8 (63%) patients. Antifungal therapy was given for a median period of 4.2 months with 5 (63%) patients having complete resolution. Three (37%) patients expired, of which 2 were attributable to IFDs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>IC fungal abscesses in children can cause significant morbidity and mortality in children with hematolymphoid cancers. Evaluation of cerebrospinal fluid galactomannan may help in early diagnosis and therapy. Prolonged antifungal therapy steered by TDM can help achieve resolution in some cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000001690","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:13:41Z","timestamp":1575908021000},"page":"e202-e206","source":"Crossref","is-referenced-by-count":8,"title":["A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies"],"prefix":"10.1097","volume":"42","author":[{"given":"Subramaniam","family":"Ramanathan","sequence":"first","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Kate","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, HCG Manavata Cancer Centre, Nashik, Maharashtra"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Kembhavi","sequence":"additional","affiliation":[{"name":"Radiodiagnosis"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badira","family":"Cheriyalinkal Parambil","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"K. C.","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cytecare hospitals Pvt. Ltd, Bangalore, Karanataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasudeva","family":"Bhat","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Prasad","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliasgar","family":"Moiyadi","sequence":"additional","affiliation":[{"name":"Neurosurgery"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Biswas","sequence":"additional","affiliation":[{"name":"Microbiology, Tata Memorial Hospital"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Narula","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shripad","family":"Banavali","sequence":"additional","affiliation":[{"name":"Pediatric Oncology"},{"name":"Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"issue":"suppl 2","key":"R1-20230918","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2001.tb00005.x","article-title":"Uncommon opportunistic fungi: new nosocomial threats","volume":"7","author":"Groll","year":"2001","journal-title":"Clan Microbiol Infect"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clan Infect Dis"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1023\/A:1008228529397","article-title":"Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin\u2019s lymphoma in India","volume":"8","author":"Advani","year":"1997","journal-title":"Ann Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12098-017-2487-x","article-title":"Fungal and parasitic CNS infections","volume":"86","author":"Singhi","year":"2017","journal-title":"Indian J Pediatr"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(18)30030-9","article-title":"Advances in the diagnosis and treatment of fungal infections of the CNS","volume":"17","author":"Schwartz","year":"2018","journal-title":"Lancet Neurol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2005.05749.x","article-title":"Management of intracranial fungal infections in patients with haematological malignancies","volume":"131","author":"Mattiuzzi","year":"2005","journal-title":"Br J Haematol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clan Infect Dis"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11926-016-0572-1","article-title":"Fungal infections and new biologic therapies","volume":"18","author":"Vallabhaneni","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/JCM.02913-15","article-title":"Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid","volume":"54","author":"Chong","year":"2016","journal-title":"J Clan Microbiol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2141.1999.01542.x","article-title":"Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay","volume":"106","author":"Kami","year":"1999","journal-title":"Br J Haematol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0971-3026.101080","article-title":"Pictorial essay: acute neurological complications in children with acute lymphoblastic leukemia","volume":"22","author":"Kembhavi","year":"2012","journal-title":"Indian J Radiol Imaging"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3174\/ajnr.A0548","article-title":"Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy","volume":"28","author":"Luthra","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1148\/rg.226025029","article-title":"Neuroimaging in pediatric leukemia and lymphoma: differential diagnosis","volume":"22","author":"Vazquez","year":"2002","journal-title":"Radiographics"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/pbc.25331","article-title":"Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients","volume":"62","author":"Carter","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0028-3886.35686","article-title":"Fungal infections of the central nervous system: a review of fungal pathogens and treatment","volume":"55","author":"Redmond","year":"2007","journal-title":"Neurol India"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/FTD.0b013e3182241b2b","article-title":"Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency","volume":"33","author":"Gerin","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12281-016-0255-4","article-title":"Therapeutic drug monitoring of posaconazole: an update","volume":"10","author":"Dekkers","year":"2016","journal-title":"Curr Fungal Infect Rep"},{"issue":"suppl","key":"R20-20230918","first-page":"374","article-title":"Improved survival in central nervous system aspergillosis: a series of immunocompromised children with leukemia undergoing stereotactic resection of aspergillomas. Report of four cases","volume":"103","author":"Middelhof","year":"2005","journal-title":"J Neurosurg"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:45:06Z","timestamp":1695012306000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001690","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}